Attachment
Helps Young Children Inhale Asthma Medications, UF Researcher
Says
Although the electronic nebulizer has long been favored by practitioners,
University of Florida clinical pharmacist Leslie Hendeles, wants
parents and physicians to know they have another option; a device
that cheaply and effectively delivers asthma medicine in a fraction
of the time, without the need for electricity and with fewer
side effects.
A metered-dose inhaler, or MDI, is the small pressurized canister
the public commonly associates with the treatment of adult asthma
patients. It requires patients to press down on the device and
inhale as the medication is released, then hold their breath
for 10 seconds.
The inhaler system Hendeles recommends is a modification of
the MDI and is designed to make delivering treatment easier for
children - and even some adults - who often have difficulty timing
the medication's release as they inhale. During the two-minute
treatment, a puff of medication is released into an attached
holding chamber in 30-second intervals, and the patient breathes
in the medicine through a mask, similar to the nebulizer's mask.
Hendeles says many physicians have been slow to recommend the
chamber attachment for young children. That's because of the
common misperception that the electronic nebulizer is more effective
at delivering medication, he says, even though it requires assembly,
cleaning, up to 20 minutes to complete the treatment and a power
source such as an electrical outlet or a car lighter. The nebulizer
is driven by compressed air and converts liquid medicine into
a fine mist that is inhaled.
"The basic message I am trying to get across to pediatricians
and family physicians is that the common misbelief that the nebulizer
is more effective is just not right. And that physicians can
make it more user-friendly for the parents to administer the
medications, so that children will get back to playing faster," says
Hendeles, who has been studying asthma medications for 25 years
and is a professor of pharmacy and pediatrics at UF's colleges
of Pharmacy and Medicine.
At the American Academy of Family Physicians' Scientific Assembly
in Dallas Wednesday, Hendeles encouraged health-care providers
to recommend the modified MDI over the nebulizer for most patients,
including infants.
A decade of research has shown the modified inhaler system is
just as effective as the nebulizer for administering quick-relief
medicines. In 1993, UF researchers, including Hendeles, published
findings in the American College of Chest Physicians' journal
Chest demonstrating that the drug albuterol for the treatment
of a sudden asthma attack was equally effective when it was given
by nebulizer or inhaler. Ninety percent of asthma patients use
albuterol to relieve acute symptoms.
According to the National Institutes of Health, more than 14
million people in the United States - including 5 million children
- have the respiratory disease.
The inhaler system also is used with young children to administer
medications such as inhaled steroids, taken on a regular twice-daily
basis to prevent asthma symptoms, even when the patient is symptom-free.
UF researchers currently are evaluating how well inhaler systems
deliver preventive medication and how much gets into the bloodstream
in children.
In addition to its convenience, the inhaler system offers other
advantages. When a nebulizer is used, a child often swallows
a lot of the medicine, causing it to be absorbed into the bloodstream.
This can lead to an elevated heart rate, tremors and agitation.
With the inhaler system, very little of the medication gets into
the bloodstream, so there are fewer side effects.
The MDI with the attached chamber also is cheaper. It costs
$20 to $50; the nebulizer system costs about $150. Each dose
of medicine administered through the MDI system costs about 5
cents, while an equivalent dose given through the nebulizer costs
about 25 cents. Overall, side effects are not as common with
the inhaler and it enables patients to use less of the drug,
Hendeles says.
As with the nebulizer, there are potential problems with the
inhaler system. Children may remove the mask or they may be upset
and unwilling to cooperate. Although Hendeles encourages the
use of the inhaler system for all children, he concedes that
the nebulizer remains an option for children who will not cooperate.
"Sometimes nebulizer therapy delivers too much medication
and leads to agitation and tremor rather than benefit," says
Dr. Gail Shapiro, a clinical professor of pediatrics at the University
of Washington School of Medicine and president-elect of the American
Academy of Allergy, Asthma and Immunology. "But there are
situations where children require high-dose therapy that is delivered
best with a nebulizer, and there are children who will not comply
with use of an MDI and (chamber attachment)."
Hendeles says even high doses of either quick-relief medicine
or preventive medicines, such as inhaled steroids, can be given
by the MDI and chamber attachment simply by increasing the number
of puffs.
In addition, some asthma-relief medications inhaled through
the nebulizer contain the preservative benzalkonium, which helps
keep the solution sterile but actually constricts the airways,
potentially decreasing the therapeutic response to the asthma-relief
medication.
"The preservative, benzalkonium, can counteract the effects
of the medicine, and the doctor and parents may not realize that
this is the reason why the patient is not responding well," says
Hendeles, whose research has been funded by various drug companies,
none of which manufacture the modified inhaler's chamber attachment.
The drug-container component of the inhaler system, along with
sterile nebulizer solutions, are designed so that they cannot
be contaminated; therefore, there is no reason to use an albuterol
product containing benzalkonium.
Hendeles says his efforts to teach physicians and patients about
the alternatives stem from wanting to make the care of an asthmatic
child as easy for parents as possible and more cost-effective
for the health-care system. |